Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Vanessa Doederlein Schwartz

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Ciencia & Saude Coletiva|May 15, 2013
[The thesis of judicialization of health care by the elites: medication for mucopolysaccharidosis]Marcelo Medeiros, Debora Diniz, Ida Vanessa Doederlein Schwartz
American Journal of Medical Genetics. Part A|March 25, 2021
Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patientsKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Journal of Patient-Reported Outcomes|May 3, 2020
Development of an inventory to assess perceived barriers related to PKU treatmentKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Orphanet Journal of Rare Diseases|September 24, 2025
Psychometric properties of perceived barriers to PKU treatment inventory in a Brazilian national sampleKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Genetics and Molecular Biology|September 21, 2018
The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?Karina Colonetti, Luiz Fernando Roesch, Ida Vanessa Doederlein Schwartz
Orphanet Journal of Rare Diseases|October 29, 2024
What is known about patients' quality of life with Phenylketonuria and their caregivers? A scoping reviewEduardo Remor, Kamilla Mueller Gabe, Katia Irie Teruya, et al.
Genetics and Molecular Biology|February 15, 2022
Characterization of the 3'UTR of the BTD gene and identification of regulatory elements and microRNAsGerda Cristal Villalba Silva, Taciane Borsatto, Ida Vanessa Doederlein Schwartz, et al.
Ciencia & Saude Coletiva|December 2, 2010
[High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders]Mônica Vinhas de Souza, Bárbara Corrêa Krug, Paulo Dornelles Picon, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
<i>GBA1</i> variants in Brazilian Gaucher disease patientsSuelen Porto Basgalupp, Vivian Altmann, Filippo Pinto E Vairo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2019
Chitotriosidase on treatment-naïve patients with Gaucher disease: A genotype vs phenotype studyFernanda Sperb-Ludwig, Bianca Lúcia Heineck, Kristiane Michelin-Tirelli, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Ciencia & Saude Coletiva|May 15, 2013
[The thesis of judicialization of health care by the elites: medication for mucopolysaccharidosis]Marcelo Medeiros, Debora Diniz, Ida Vanessa Doederlein Schwartz
American Journal of Medical Genetics. Part A|March 25, 2021
Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patientsKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Journal of Patient-Reported Outcomes|May 3, 2020
Development of an inventory to assess perceived barriers related to PKU treatmentKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Orphanet Journal of Rare Diseases|September 24, 2025
Psychometric properties of perceived barriers to PKU treatment inventory in a Brazilian national sampleKatia Irie Teruya, Eduardo Remor, Ida Vanessa Doederlein Schwartz
Genetics and Molecular Biology|September 21, 2018
The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?Karina Colonetti, Luiz Fernando Roesch, Ida Vanessa Doederlein Schwartz
Orphanet Journal of Rare Diseases|October 29, 2024
What is known about patients' quality of life with Phenylketonuria and their caregivers? A scoping reviewEduardo Remor, Kamilla Mueller Gabe, Katia Irie Teruya, et al.
Genetics and Molecular Biology|February 15, 2022
Characterization of the 3'UTR of the BTD gene and identification of regulatory elements and microRNAsGerda Cristal Villalba Silva, Taciane Borsatto, Ida Vanessa Doederlein Schwartz, et al.
Ciencia & Saude Coletiva|December 2, 2010
[High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders]Mônica Vinhas de Souza, Bárbara Corrêa Krug, Paulo Dornelles Picon, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
<i>GBA1</i> variants in Brazilian Gaucher disease patientsSuelen Porto Basgalupp, Vivian Altmann, Filippo Pinto E Vairo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2019
Chitotriosidase on treatment-naïve patients with Gaucher disease: A genotype vs phenotype studyFernanda Sperb-Ludwig, Bianca Lúcia Heineck, Kristiane Michelin-Tirelli, et al.
Pageof 9